我院2009-2011年医院制剂的生产与使用情况分析

Analysis of the Production and Application of Hospital Preparation in Our Hospital during 2009-2011

目的:分析我院(传染病专科医院)医院制剂的生产与应用情况,为医院制剂的可持续发展提供保障。方法:通过医院制剂信息管理系统,对我院2009-2011年医院制剂的使用量排序、使用金额排序、停止生产医院制剂及停产原因进行统计。结果与结论:我院2009-2011年间医院制剂使用量排列首位的2009年为肝得宁丸(降酶类制剂,249 636瓶),2010、2011年均为恩替卡韦分散片(抗病毒类制剂,分别为265 554、508 589瓶);使用金额排名最后一位的2009年为新肝灵颗粒剂(降酶类制剂,2 165.30元),2010、2011年均为磷酸苦参碱注射液(退黄类制剂,分别为609.30、0元);3年间停止生产的医院制剂包括33%硫酸镁溶液、炉甘石洗剂等6种,均由使用量少、成本高的原因而导致停产。我院医院制剂的研发应着重考虑在市场不供应的品种上,同时加强新剂型、新品种的研发力度,并发挥专科医院以中医治疗为主的特色,研发中药制剂。

OBJECTIVE： To analyze the production and application of hospital preparation in our hospital（infectious disease specialist hospital）,and to provide guarantee for sustainable development of hospital preparation.METHODS： Depending on the information management system of hospital preparation,we have carried our statistical analysis of the amount and cost of hospital preparation,end-of-life preparation and reasons for cessation of production in our hospital during 2009-2011.RESULTS CONCLUSIONS： Top 1 drug in the list of amount were Gandening pills（preparation for reducing liver enzyme,249 636 bottles） in 2009,Entecavir dispersible tablets（antiviral preparation,265 554 and 508 589 bottles） in 2010 and 2011.The last drug in term of cost were Xinganling granules（agents for lowering enzymes,2 165.30 yuan） in 2009,Matrine phosphoric acid injection（agents for jaundice,609.30 yuan and 0 yuan） in 2010 and 2011.End-of-life preparations were 33% magnesium sulfate solution,calamine lotion and other 4 drugs,and they were resulted from low amount and high cost.We should consider about the types which have been not supplied in the market,enhance RD of new dosage form and new types,play the characteristics of specialist hospital mainly based on TCM treatment and research and develop TCM preparations.